Iran's foreign ministry said new U.S. economic measures amount to state terrorism.

Guangdong Securities Regulatory Bureau said Zhuhai Zhongpu Private Fund Management Co. failed to truthfully report investors and actual controllers to the Asset Management Association of China (AMAC) and did not complete required filing for the Zibo Puda Equity Investment Partnership (Limited Partnership). The bureau issued an administrative warning letter, ordered the firm to rectify the deficiencies, hold responsible personnel accountable, and submit a written rectification report within 30 days of receipt of the decision.

China's Shanghai Composite Index closed down 0.11%, the Shenzhen Composite Index fell 0.68% and the ChiNext Index declined 1.41%. Combined turnover on the Shanghai and Shenzhen bourses was CNY2.1 trillion, down CNY24.2 billion versus the prior session. The agricultural planting sector extended gains: Wanxiang Denong recorded a nine-day run with six daily limit-ups and Xinsai Co. posted a second straight limit-up. Chemical pharmaceutical names rallied into the close—Yuheng Pharmaceutical hit the limit, with Dongya Pharmaceutical, Shenqi Pharmaceutical, Keyuan Pharmaceutical, Haixiang Pharmaceutical and Zhongzhe Fine Chemical also rising. Real estate stocks showed strength; Shenwuye A and I Love My Home hit daily limits, while Tefa Service, WorldUnion (Shilianhang), Tibet Urban Investment, Shahe Co. and Fuxing shares advanced. CRO-related stocks slid sharply: Wanbang Pharmaceutical plunged more than 15%, Jin'an Protein and CanSino Biologics dropped over 10%, and Baihua Pharma, Hongbo Pharma, Lanwei Medical, Boji Pharmaceutical and Chengda Pharmaceutical also fell.